Role of viral and host factors in HCV persistence: Which lesson for therapeutic and preventive strategies?

Digestive and Liver Disease

Volumn 36, Issue 11, 2004, Pages 703-711

  Missale, G ^a   Cariani, E ^a   Ferrari, Cafer ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Hepatitis C virus (HCV); Innate immunity; T cell response

Indexed keywords

GAMMA INTERFERON; HEPATITIS C VACCINE; INTERFERON; PERFORIN; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; CELL MATURATION; CYTOKINE PRODUCTION; CYTOLYSIS; DENDRITIC CELL; DRUG SYNTHESIS; HEPATITIS C; HEPATITIS C VIRUS; HOST CELL; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION CONTROL; INNATE IMMUNITY; NATURAL KILLER CELL; PATHOGENESIS; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION; VIRUS RESISTANCE; IMMUNOLOGY; PATHOGENICITY; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY;

HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; T-LYMPHOCYTES;

EID: 17644382994     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2004.07.004     Document Type: Review

References (101)

1. S. Cooper A. Erickson E. Adams J. Kansopon A. Weiner D. Chien et al. Analysis of a successful immune response against hepatitis C virus Immunity 2 1999 439-449
2. R. Thimme D. Oldach K.M. Chang C. Steiger S.C. Ray F.V. Chisari Determinants of viral clearance and persistence during acute hepatitis C virus infection J. Exp. Med. 194 2001 1395-1406
3. R. Thimme J. Bukh H.C. Spangenberg S. Wieland J. Pemberton C. Steiger et al. Viral and immunological determinants of hepatitis C virus clearance, persistence and disease Proc. Natl. Acad. Sci. USA 99 2002 15661-15668
4. N.H. Shoukry A. Grakoui M. Houghton D.Y. Chien J. Ghrayeb K.A. Reimann C.M. Walker Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection J. Exp. Med. 197 2003 1645-1655
5. A. Grakoui N.H. Shoukry D.J. Woollard J.H. Han H.L. Hanson J. Ghrayeb et al. HCV persistence and immune evasion in the absence of memory cell help Science 302 2003 659-662
6. P. Bottarelli M. Brunetto M. Minutello P. Calvo D. Unutmaz A. Weiner et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection Gastroenterology 24 1993 580-587
7. G. Missale R. Bertoni V. Lamonaca A. Valli M. Massari C. Mori et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response J. Clin. Invest. 98 1996 706-714
8. H.M. Diepolder R. Zachoval R.M. Hoffmann E. Wierenga T. Santantonio M.C. Jung et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection Lancet 346 1995 206-207
9. M. Cramp P. Carucci S. Rossol S. Chokshi G. Maertens R. Williams et al. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients with hepatitis C viremia Gut 44 1999 41-49
10. N.H. Gruener T.J. Gerlach M.C. Jung H.M. Diepolder C.A. Schirren W.W. Schraut et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C J. Infect. Dis. 181 2000 1528-1536
11. F. Lechner D. Wong P. Dunbar R. Chapman R. Chung P. Dohrenwend et al. Analysis of successful immune responses in persons infected with hepatitis C virus J. Exp. Med. 191 2000 1499-1512
12. M. Lechmann H.G. Ihlenfeldt I. Bsraunschweiger G. Giers G. Jung B. Matz et al. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia Hepatology 1 1996 790-795
13. K-M. Chang R. Thimme J. Melpolder D. Oldach J. Pemberton J. Moorhead-Lodis et al. Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection Hepatology 33 2001 267-276
14. S.L. Tsai Y.F. Liaw M.H. Chen C.Y. Huang G.C. Kuo Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity Hepatology 3 1997 449-458
15. R.P. Woitas M. Lechmann G. Jung R. Kaiser T. Sauerbruch U. Spengler CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes J. Immunol. 159 1997 212-218
16. S.M. Kamal J.W. Rasenack L. Bianchi A. Al Tawil K. El Sayed Khalifa T. Peter et al. Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response Gastroenterology 121 2001 646-656
17. A. Zibert H. Meisel W. Kraas A. Schulz G. Jung M. Roggendorf Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus Hepatology 3 1997 115-119
18. P. Farci A. Shimoda D. Wong T. Cabezon D. De Gioannis A. Strazzera et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein Proc. Natl. Acad. Sci. USA 93 1996 15394-15399
19. S.A. Kalams B.D. Walker The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses J. Exp. Med. 188 1998 2199-2204
20. A. Ciurea L. Hunziker P. Klenerman H. Hengartner R.M. Zinkernagel Impairment of CD4(+) T-cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants J. Exp. Med. 193 2001 297-305
21. M. Chen M. Sallberg A. Sonnerborg O. Weiland L. Mattsson L. Jin et al. Limited humoral immunity in hepatitis C virus infection Gastroenterology 116 1999 135-143
22. R.A. Koup J.T. Safrit Y. Cao C.A. Andrews G. McLeod W. Borkowsky et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome J. Virol. 68 1994 4650-4655
23. R.J. Rentenaar L.E. Gamadia N. van DerHoek F.N. van Diepen R. Boom J.F. Weel et al. Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection J. Clin. Invest. 3 2000 541-548
24. M.E. Major K. Mihalik J. Fernandez J. Seidman D. Kleiner A.A. Kolykhalov et al. Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus J. Virol. 73 1999 3317-3323
25. M.E. Major K. Mihalik M. Puig B. Rehermann M. Nascimbeni C.M. Rice et al. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge J. Virol. 76 2002 6586-6595
26. S.E. Bassett K.M. Brasky R.E. Lanford Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles J. Virol. 72 1998 389-399
27. S.E. Bassett B. Guerra K. Brasky E. Miskovsky M. Houghton G.R. Klimpel et al. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection Hepatology 33 2001 1479-1487
28. J.J. Post Y. Pan A.J. Freeman C.E. Harvey P.A. White P. Palladinetti et al. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort J. Infect. Dis. 189 2004 1846-1855
29. M.T. Shata N. Tricoche M. Perkus D. Tom B. Brotman P. McCormack et al. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees Virology 314 2003 601-616
30. S. Urbani C. Boni G. Missale G. Elia C. Cavallo M. Massari et al. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C J. Virol. 76 2002 1123-1134
31. N.H. Gruener F. Lechner M.C. Jung H. Diepolder T. Gerlach G. Lauer et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus J. Virol. 75 2001 5550-5558
32. A.U. Neumann N.P. Lam H. Dahari D.R. Gretch T.E. Wiley T.J. Layden et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy Science 282 1998 23-27
33. Y.K. Shimizu M. Hijikata A. Iwamoto H.J. Alter R.H. Purcell H. Yoshikura et al. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses J. Virol. 68 1994 1494-1500
34. P. Farci A. Shimoda A. Coiana G. Diaz G. Peddis J.C. Melpolder et al. The outcome of acute hepatitis C predicted by the evolution of viral quasispecies Science 288 2000 339-344
35. M.U. Mondelli A. Cerino L. Segagni A. Meola A. Cividini E. Silini et al. Hypervariable region 1 of hepatitis C virus: Immunological decoy or biologically relevant domain? Antiviral. Res. 52 2001 153-159
36. A. Weiner A.L. Erickson J. Kansopon K. Crawford E. Muchmore A.L. Hughes et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant Proc. Natl. Acad. Sci. USA 92 1995 2755-2759
37. H. Wang D.D. Eckels Mutations in immunodominant T-cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T-cell recognition J. Immunol. 162 1999 4177-4183
38. A.L. Erickson Y. Kimura S. Igarashi J. Eichelberger M. Houghton J. Sidney et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes Immunity 15 2001 883-895
39. B. Rehermann P. Fowler J. Sidney J. Person A. Redeker M. Brown et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis J. Exp. Med. 181 1995 247-258
40. K.M. Chang B. Rehermann J.G. McHutchinson C. Pasquinelli S. Southwood A. Sette et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus J. Clin. Invest. 20 1997 2376-2385
41. L. Frasca P. Del Porto L. Tuosto B. Marinari C. Scotta M. Carbonari et al. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells J. Immunol. 163 1999 650-658
42. J.H. Wang T.J. Layden D.D. Eckels Modulation of the peripheral T-cell response by CD4 mutants of hepatitis C virus: Transition from a Th1 to a Th2 response Hum. Immunol. 64 2003 662-673
43. H. Wedemeyer X.S. He M. Nascimbeni A.R. Davis H.B. Greenberg J.H. Hoofnagle et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection J. Immunol. 69 2002 3447-3458
44. V. Appay P.R. Dunbar M. Callan P. Klenerman G.M. Gillespie L. Papagno et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections Nat. Med. 8 2002 379-385
45. R. Welsh Assessing CD8 T-cell number and dysfunction in the presence of antigen J. Exp. Med. 193 2001 F19-F22
46. M.K. Large D. Kittlesen Y.S. Hahn Suppression of host immune response by the core protein of hepatitis C virus: Possible implications for hepatitis C virus persistence J. Immunol. 162 1999 931-938
47. D.J. Kittlesen K.A. Chianese-Bullock Z.Q. Yao T.J. Braciale Y.S. Hahn Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation J. Clin. Invest. 26 2000 1239-1249
48. T. Kanto N. Hayashi T. Takehara T. Tatsumi N. Kuzushita A. Ito et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals J. Immunol. 162 1999 5584-5591
49. C. Bain A. Fatmi F. Zoulim J.P. Zarski C. Trepo G. Inchauspe Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection Gastroenterology 120 2001 512-521
50. S. Auffermann-Gretzinger E.B. Keeffe S. Levy Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection Blood 97 2001 3171-3176
51. V. Brinkmann T. Geiger S. Alkan C.H. Heusser Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells J. Exp. Med. 178 1993 1655-1663
52. T. Luft K.C. Pang E. Thomas P. Hertzog D.N. Hart J. Trapani et al. Type I IFNs enhance the terminal differentiation of dendritic cells J. Immunol. 161 1998 1947-1953
53. G. Dusheiko J. Main H. Thomas O. Reichard C. Lee A. Dhillon et al. Ribavirin treatment for patients with chronic hepatitis C: Results of a placebo-controlled study J. Hepatol. 25 1996 591-598
54. R.C. Tam B. Pai J. Bard C. Lim D.R. Averett U.T. Phan et al. Ribavirin polarizes human T-cell responses towards a Type 1 cytokine profile J. Hepatol. 30 1999 376-382
55. H.F. Lohr G. Gerken M. Roth S. Weyer J.F. Schlaak K.H. Meyer zum Buschenfelde The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome J. Hepatol. 29 1998 524-532
56. G. Missale E. Cariani V. Lamonaca A. Ravaggi A. Rossini R. Bertoni et al. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients Hepatology 26 1997 792-797
57. E. Barnes G. Harcourt D. Brown M. Lucas R. Phillips G. Dusheiko et al. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection Hepatology 36 2002 743-754
58. S.M. Kamal J. Fehr B. Roesler T. Peters J.W. Rasenack et al. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C Gastroenterology 123 2002 1070-1083
59. D. Accapezzato V. Francavilla P. Rawson A. Cerino A. Cividini M.U. Mondelli et al. Subversion of effector CD8+ T-cell differentiation in acute hepatitis C virus infection: The role of the virus Eur. J. Immunol. 34 2004 438-446
60. A. Bergqvist S. Sundstrom L.Y. Dimberg E. Gylfe M.G. Masucci The hepatitis C virus core protein modulates T-cell responses by inducing spontaneous and altering T-cell receptor-triggered Ca2+ oscillations J. Biol. Chem. 278 2003 18877-18883
61. C.H. Lee Y.H. Choi S.H. Yang C.W. Lee S.J. Ha Y.C. Sung Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages Virology 279 2001 271-279
62. Z.Q. Yao D.T. Nguyen A.I. Hiotellis J.S. Hahn Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway J. Immunol. 167 2001 5264-5272
63. N. Goutagny A. Fatmi V. De Ledinghen F. Penin P. Couzigou G. Inchauspe et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection J. Infect. Dis. 187 2003 1951-1958
64. P. Sarobe J.J. Lasarte N. Casares A. Lopez-Diaz De Cerio E. Baixeras P. et al. Labarga Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins J. Virol. 2002 5062-5070
65. M.T. Brady A.J. MacDonald A.G. Rowan K.H. Mills Hepatitis virus non-structural protein 4 suppresses Th1 responses by stimulating IL-2 production from monocytes Eur. J. Immunol. 33 2003 3448-3457
66. A. Dolganiuc K. Kodys A. Kopasz C. Marshall T. Do L. Romics et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation J. Immunol. 170 2003 5615-5621
67. R.S. Longman A.H. Talal I.M. Jacobson M.L. Albert C.M. Rice Presence of functional dendritic cells in patients chronically infected with hepatitis C virus Blood 23 2004 226-229
68. K.D. Tardif A. Siddiqui Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells J. Virol. 77 2003 11644-11650
69. K.V. Konan T.H. Giddings Jr. M. Ikeda K. Li S.M. Lemon K. Kirkegaard Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus J. Virol. 77 2003 7843-7855
70. K. Herzer C.S. Fak J. Encke S.T. Eichhorst A. Ulsenheimer B. Selinger et al. Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity J. Virol. 77 2003 8299-8309
71. A.I. Su J.P. Pezacki L. Wodicka AD. Brideau L. Supekova R. Thimme et al. Genomic analysis of the host response in hepatitis C virus infection Proc. Natl. Acad. Sci. USA 99 2002 15669-15674
72. J. Pflugheber B. Fredericksen R. Sumpter Jr. C. Wang F. Ware D.L. Sodora et al. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication Proc. Natl. Acad. Sci. USA 99 2002 4650-4655
73. M. Gale M.J. Korth N.M. Tang S.L. Tan D.A. Hopkins T.E. Dever et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural A protein Virology 230 1997 217-227
74. M. Gale B. Kwieciszewski M. Dossett H. Nakao M.G. Katze Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase J. Virol. 73 1999 6506-6516
75. N. Enomoto I. Sakuma Y. Asahina M. Kurosaki T. Murakami C. Yamamoto et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection N. Engl. J. Med. 334 1996 77-81
76. D.R. Taylor S.T. Shi P.R. Romano G.N. Barber M.M. Lai Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein Science 285 1999 27-32
77. E. Foy K. Li C. Wang R. Sumpter M. Ikeda S.M. Lemon et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease Science 300 2003 1145-1148
78. M.H. Heim D. Moradpour H.E. Blum Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway J. Virol. 73 1999 8469-8475
79. A. Blindenbacher H.T. Duong L. Hunziker S.T. Stutvoet X. Wang L. Terracciano et al. Expression of hepatitis C virus proteins inhibits interferon α signaling in the liver of transgenic mice Gastroenterology 11 2003 1465-1475
80. D. Tai S. Tsai Y. Chen Y. Chuang C. Peng I. Sheen et al. Activation of nuclear factor kappa B in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis Hepatology 31 2000 656-664
81. H. Marusawa M. Hijikata T. Chiba K. Shimotohno Hepatitis virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κB activation J. Virol. 73 1999 4713-4720
82. H. Bantel K. Schulze-Osthoff Apoptosis in hepatitis C virus infection Cell Death Differ. 2 2003 48-58
83. N. Hiramatsu N. Hayashi K. Katayama K. Mochizuki Y. Kawanishi A. Kasahara et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C Hepatology 19 1994 1354-1359
84. J. Hayashi Y. Kishihara K. Yamaji N. Furusyo T. Yamamoto Y. Pae et al. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection Hepatology 3 1997 697-701
85. E. Mita N. Hayashi S. Iio T. Takehara T. Hijioka A. Kasahara et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection Biochem. Biophys. Res. Commun. 204 1994 468-474
86. S. Pianko S. Patella G. Ostapowicz P. Desmond W. Sievert Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection J. Viral. Hepat. 8 2001 406-413
87. C. Gremion B. Grabscheid B. Wolk D. Moradpour J. Reichen W. Pichler et al. Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction J. Virol. 78 2004 2152-2157
88. R. Gonzalez-Amaro C. Garcia-Monzon L. Garcia-Buey R. Moreno-Otero J.L. Alonso E. Yague et al. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis J. Exp. Med. 179 1994 841-848
89. M.J. Koziel D. Dudley N. Afdhal A. Grakoui C.M. Rice Q.L. Choo et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release J. Clin. Invest. 96 1995 2311-2321
90. K. Ando K. Hiroishi T. Kaneko T. Moriyama Y. Muto N. Kayagaki et al. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL J. Immunol. 158 1997 5283-5291
91. R.B. Ray K. Meyer R. Ray Suppression of apoptotic cell death by hepatitis C virus core protein Virology 226 1996 176-182
92. R.B. Ray K. Meyer R. Steele A. Shrivastava B.B. Aggarwal R. Ray Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein J. Biol. Chem. 273 1998 236-239
93. K. Machida K. Tsukiyama-Kohara E. Seike S. Tone F. Shibasaki M. Shimizu et al. Inhibition of cytochrome C release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins J. Biol. Chem. 276 2001 12140-12146
94. S. Balachandran C.N. Kim W.C. Yeh T.W. Mak K. Bhalla G.N. Barber Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling EMBO J. 17 1998 6888-6902
95. S. Balachandran P.C. Roberts L.E. Brown H. Truong A.K. Pattnaik D.R. Archer et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection Immunity 13 2000 129-141
96. P. Pileri Y. Uematsu S. Campagnoli G. Galli F. Falugi R. Petracca et al. Binding of hepatitis C virus to CD81 Science 282 1998 938-941
97. S. Crotta A. Stilla A. Wack A. D'Andrea S. Nuti U. D'Oro et al. Inhibition of natural killer cells through the engagement of CD81 by the major hepatitis C virus envelope protein J. Exp. Med. 195 2002 35-41
98. C.T. Tseng G.R. Klimpel Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions J. Exp. Med. 195 2002 43-49
99. A. Wack E. Soldaini C. Tseng S. Nuti G. Klimpel S. Abrignani Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells Eur. J. Immunol. 31 2001 166-175
100. M. Jinushi T. Takehara T. Kanto T. Tatsumi V. Groh T. Spies et al. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: Impairment in chronic hepatitis C virus infection J. Immunol. 170 2003 1249-1256
101. X. Forns J. Bukh R.H. Purcell The challenge of developing a vaccine against hepatitis C virus J. Hepatol. 37 2002 684-695